Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Rita
Rita Agostinetto, Rocca Di Papa IT
| Patent application number | Description | Published |
|---|---|---|
| 20100261649 | LH LIQUID FORMULATIONS - The invention relates to liquid pharmaceutical formulations of luteinizing hormone (LH) for single- or multi-dose administration. | 10-14-2010 |
| 20100310649 | SOLID LIPID MICROCAPSULES CONTAINING GROWTH HORMONE INNER CORE MICROPARTICLES - The invention relates to growth hormone (GH) formulations having sustained-release properties, in particular human growth hormone (hGH) and methods for their preparation. The growth hormone formulations can be manufactured without denaturing of the protein and can conveniently be administrated to the person in need thereof by using a conventional syringe via a needle having a small diameter. | 12-09-2010 |
Rita Asquini, Roma IT
| Patent application number | Description | Published |
|---|---|---|
| 20090317032 | Electro-Optical Tunable Filter and Manufacturing Process - An electro-optical filter made of a support in which an optical guide with a diffused channel waveguide and of a cover, that are created in borosilicate glass, and which includes a gap obtained by the use of suitable spacers, filled with a grating constituted of alternating strips of polymer and liquid crystal called POLICRYPS (Polymer Liquid CRYstal Polymer Slices), and with first electrodes that are coplanar to the support and next to the optical guide with a channel, that electrically control the grating making the filter tunable, and a manufacturing process. | 12-24-2009 |
Rita Balice-Gordon, Glen Mills, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090055940 | ZEBRAFISH MODEL OF MLL LEUKEMOGENESIS - The zebrafish mll gene and methods of use thereof are provided. | 02-26-2009 |
Rita Banzi, Pieve Di Cento IT
| Patent application number | Description | Published |
|---|---|---|
| 20090093521 | 2, 5-Bis-Diamine [1,4] Benzoquinone-Derivatives - Synthesis of 2,5-bis-diamine-[1,4]benzoquinonic derivatives having the general formula (I), products and intermediates of said synthesis; the synthesis involves the use of p-benzoquinones having the general formula (IX) and diamines having the general formula (XI). | 04-09-2009 |
Rita Blankenburg, Hamburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20080221165 | Use of Octenidine Dihydrochloride in Semisolid Preparations - The invention relates to the use of octenidine dihydrochloride for manufacturing a semisolid pharmaceutical composition for the treatment of wounds, atopic dermatitides, infected eczemas, dermatomycoses, vaginal infections, acne, herpes and/or for controlling multidrug-resistant pathogens, where the composition comprises from 0.005 to 5% by weight octenidine dihydrochloride, and a corresponding composition. | 09-11-2008 |
Rita Bortell, Shirley, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090203878 | TRYPTOPHAN AS A FUNCTIONAL REPLACEMENT FOR ADP-RIBOSE-ARGININE IN RECOMBINANT PROTEINS - A method is disclosed for producing a polypeptide with a modified activity or stability, by replacing an arginine residue capable of being ADP-ribosylated with a tryptophan or a phenylalanine. In one embodiment, compositions are provided that include polypeptides, such as alpha defensin, with arginine-to-tryptophan or arginine-to-phenylalanine substitutions, where the arginine residue is capable of being ADP-ribosylated. In another embodiment, methods are disclosed for modifying an immune response in a subject. | 08-13-2009 |
Rita Cannas, Duebendorf CH
| Patent application number | Description | Published |
|---|---|---|
| 20090022764 | ORGANIC COMPOUNDS - The present invention refers to a process for the production of controlled-release aqueous compositions comprising an active ingredient releasably contained within polymeric particles. The polymeric particles are obtainable by ring-opening metathesis polymerisation of a monomer of the general formula (I) | 01-22-2009 |
Rita Cucchiara, Modena IT
| Patent application number | Description | Published |
|---|---|---|
| 20100284608 | FEATURE-BASED SEGMENTATION METHOD, FOR SEGMENTING A PLURALITY OF LOOSELY-ARRANGED DUPLICATE ARTICLES AND A GROUP FOR ACTUATING THE METHOD FOR SUPPLYING A PACKAGING MACHINE - The invention relates to a segmentation method based on the characteristics for segmenting a plurality of duplicate articles ( | 11-11-2010 |
Rita Di Donato, Cava De' Tirreni IT
| Patent application number | Description | Published |
|---|---|---|
| 20100316195 | LAWFUL INTERCEPTION OF NON-LOCAL SUBSCRIBERS - The present application relates to monitoring non-local originating calls in a telecommunication system having a local network part and a non-local network part. A monitoring centre is attached to an Intercept Access Point in the local network part. A monitoring request comprising an external target identification is received from the monitoring centre to the Intercept Access point. A call is set-up of from an originating subscriber in the non-local network part, towards the local network part. An Initial Address Message comprising the originating subscriber's identity is received to the Intercept Access point from the non-local network part. A match is found between the Initial Address Message and the received target identification. Monitoring information related to the matched target is transferred from the Intercept Access Point to the monitoring centre. | 12-16-2010 |
| 20110032840 | ONE ACTIVITY REPORT FOR INTERCEPTION PURPOSES - The present invention relates to methods and arrangements for optimizing monitoring capacity in a telecommunication system comprising at least one information element receiving unit. One activity report request along with identities of a target to be monitored are received at the element receiving unit. At least two information elements belonging to a first element group, related to the specified target by different identities and comprise duplicate information are also received at the target. The element receiving unit selects one of the received at least two elements. | 02-10-2011 |
Rita Faddoul, Grenoble FR
| Patent application number | Description | Published |
|---|---|---|
| 20110034608 | FINISHING COMPOUND SUITABLE FOR AN ACOUSTIC SUPPORT - A finishing compound having acoustic properties and including in percentage by weight relative to the total weight of the product, at least 25 to 80% of water; 0.1 to 5% of a thickening agent; 0.01 to 0.8% of a dispersing agent; 10 to 60% of a monogranular filler wherein the D | 02-10-2011 |
| 20110042163 | FINISHING COMPOUND SUITABLE FOR ACOUSTIC SUPPORTS - A finishing compound having acoustic properties and including iii percentage by weight relative to the total weight of the product, at least 10 to 70% of water; 0.1 to 5% of a foaming agent; 0.1 to 5% of a thickening agent; 35 to 70% of a monogranular filler having a size greater than or equal to 100 μm and excluding fine fillers; 0.1 to 8% of synthetic or animal fibres; 0.5 to 35% of binder. | 02-24-2011 |
Rita Fiaschi, Pisa IT
| Patent application number | Description | Published |
|---|---|---|
| 20090292129 | PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST - A process for resolving a compound in racemic form comprising the following steps is described: a) reacting a compound in racemic form with a resolving agent, b) forming a diastereoisomeric complex of the resolving agent and an enantiomer of interest, c) separating the enantiomer of interest from the obtained diastereoisomer, wherein such a process is characterized in that said resolving agent is a compound of Formula (I). A diastereoisomeric complex between the resolving agent of Formula (I) and the enantiomer of interest is also described. The process according to the invention allows acid and basic racemic mixtures to be separated. | 11-26-2009 |
Rita Fishelevich, Baltimore, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20080241187 | STABILIZATION OF VIRAL COMPOSITIONS - This invention concerns stabilized virus compositions, preferably a herpesvirus which may be an attenuated or genetically modified herpes simplex virus or varicella zoster virus, and a method of stabilizing viruses and immunizing preparations by the addition of sugars, preferably glucose and amino acids, preferably lysine. | 10-02-2008 |
Rita Fügemann, Marl DE
| Patent application number | Description | Published |
|---|---|---|
| 20110014437 | TRANSPARENT ELECTRICALLY CONDUCTIVE LAYER, A PROCESS FOR PRODUCING THE LAYER AND ITS USE - Transparent, electrically conductive layer, a process for producing the layer and its use, wherein the layer is based on at least one compound of the formula 1 | 01-20-2011 |
Rita Fügemann, Marl DE
| Patent application number | Description | Published |
|---|---|---|
| 20080233378 | TRANSPARENT, ELECTRICALLY CONDUCTIVE LAYER, A PROCESS FOR PRODUCING THE LAYER AND ITS USE - Transparent, electrically conductive layer, a process for producing the layer and its use, wherein the layer is based on at least one compound of the formula 1 | 09-25-2008 |
| 20110014437 | TRANSPARENT ELECTRICALLY CONDUCTIVE LAYER, A PROCESS FOR PRODUCING THE LAYER AND ITS USE - Transparent, electrically conductive layer, a process for producing the layer and its use, wherein the layer is based on at least one compound of the formula 1 | 01-20-2011 |
Rita Haerteis, Ried-Kochel A. S. DE
| Patent application number | Description | Published |
|---|---|---|
| 20080248535 | RAPID ONE-STEP REVERSE TRANSCRIPTASE PCR - The present invention is directed to a method for performing a one-step RT-PCR for amplifying a target RNA comprising the steps (i) providing a sample which is supposed to contain said target RNA (ii) adding a reaction mixture comprising all reagents necessary to reverse transcribe said target RNA into cDNA and amplify at least a portion of said cDNA (iii) incubating said sample for a time interval of 0 seconds to 40 seconds at a temperature between 20° C. and 65° C., and (iv) subjecting said sample to multiple cycles of a thermocycling protocol wherein the temperature of said sample is varied between at least a first temperature between 37° C. and 72° C. and a second temperature between 85° C. and 100° C. | 10-09-2008 |
Rita Hoffmann, Rahden DE
| Patent application number | Description | Published |
|---|---|---|
| 20090290845 | HOUSING FOR OPTICAL WAVEGUIDE FERRULE - A housing ( | 11-26-2009 |
| 20100220959 | CONNECTOR FOR OPTICAL WAVEGUIDES - In order to realize an exact contacting of optical waveguides in connectors, the invention proposes a connector for optical waveguides, particularly for being mated and contacted with a mating connector that is equipped with an optoelectric receiver, wherein two optical waveguides are respectively arranged within a ferrule housing in a spring-loaded fashion in individual ferrules and can be axially displaced independently of one another. The ferrule housings are also arranged in a sliding housing that is arranged within a surrounding connector housing such that it can be axially displaced by a certain supplementary travel, namely also in a spring-loaded fashion. This makes it possible to reliably compensate manufacturing-related dimensional tolerances between the ferrule housings and the optoelectric receivers in a mating connector or another adapter. | 09-02-2010 |
Rita Humeniuk, Gaithersburg, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20100151004 | MODULATION OF DRUG SENSITIVITY - Methods for the treatment of disorders, including cancer, are described which include administering to a subject a DNA methylation inhibitor and an antineoplastic agent. Compositions containing a DNA methylation inhibitor and an antineoplastic agent, which are useful in treating disorders including cancer, are also described. Additionally, methods useful for developing a prognosis for or diagnosing a subject's development of resistance to treatment with a chemotherapeutic agent are described. | 06-17-2010 |
| 20110020291 | USE OF STEM CELLS FOR WOUND HEALING - Cells, compositions, and methods of cell therapy for administering a therapeutically effective amount of stem cells or cell concentrate to achieve accelerated wound healing of normal and chronic wounds, while minimizing the formation of scar tissue. | 01-27-2011 |
Rita La Spina, Sheffield GB
| Patent application number | Description | Published |
|---|---|---|
| 20090026407 | ADHESIVE MATERIALS - A reversibly adhesive combination comprising a first component having a first surface and a second component having a second surface, the respective components being adhesively attachable when said surfaces are in contact and the combination is subject to environmental conditions of a first type and the components being separable when the combination is subject to environmental conditions of a second type wherein the first and second components respectively comprise oppositely charged polyelectrolytes. Typically the polyelectrolytes are respectively a polyacid and a polybase. Typically the environmental conditions are represented by pH. | 01-29-2009 |
Rita Leirich, Munchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100142512 | METHOD AND ARRANGEMENT FOR AUTOMATICALLY UPDATING A WHITE LIST - The invention relates to a method and a system and devices for session control in a communications network, whereby subscriber-specific data (D) of a subscriber (B) called by a calling subscriber (A) for the purpose of call completion (C) are stored in a list (WL), associated with the subscriber (A) to be called, for administering subscriber-specific data (D) of trustworthy subscribers. The subscriber-specific data (D) concerning the called subscriber (B) are automatically stored in the list (WL). | 06-10-2010 |
Rita Meskiene, Vilnius LT
| Patent application number | Description | Published |
|---|---|---|
| 20090087874 | GLUCOSE DEHYDROGENASE AND PRODUCTION THEREOF - The invention relates to novel PQQ-dependent soluble glucose dehydrogenases (sPQQGDH) from | 04-02-2009 |
Rita Mitnacht-Kraus, Bad Vilbel DE
| Patent application number | Description | Published |
|---|---|---|
| 20110223182 | MONOCLONAL ANTIBODIES FOR TREATMENT OF CANCER - The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing GT468, including tumor-related diseases such as breast Cancer, lung Cancer, gastric Cancer, ovarian Cancer, hepatocellular Cancer, colon Cancer, pancreatic Cancer, esophageal Cancer, head & neck Cancer, kidney Cancer, in particular renal cell Carcinoma, prostate Cancer, liver cancer, melanoma, sarcoma, myeloma, neuroblastoma, placental choriocarcinoma, cervical cancer, and thyroid Cancer, and the metastatic forms thereof. In one embodiment, the rumor disease is metastatic cancer in the lung. | 09-15-2011 |
Rita Mozes-Koch, Yavne IL
| Patent application number | Description | Published |
|---|---|---|
| 20100071088 | Plant Expression Constructs and Methods of Utilizing Same - A Geminivirus based expression construct being capable of systemic symptomeless spread in a plant host is provided as well as methods of utilizing same for plant gene expression, gene silencing and plant protection. | 03-18-2010 |
| 20110162106 | PLANT EXPRESSION CONSTRUCTS COMPRISING AND USES THEREOF - Methods of expressing a molecule of interest in a plant are disclosed. One method comprises contacting roots of the plant in a solution comprising at least one Geminivirus based expression construct so as to allow the at least one Geminivirus based expression construct to be absorbed by the roots, the expression construct comprising a polynucleotide encoding the molecule of interest, and further the expression construct being capable of systemic symptomless spread in a plant host, thereby expressing a molecule of interest in a plant. Expression constructs capable of systemic symptomless spread in a host plant are also disclosed. | 06-30-2011 |
Rita Noumeir, Saint Laurent CA
| Patent application number | Description | Published |
|---|---|---|
| 20090164474 | METHODS AND SYSTEMS FOR CONSOLIDATING MEDICAL INFORMATION - Methods and systems for enabling data communication from an image archiving system and a data storage/index/retrieving system. | 06-25-2009 |
Rita Preston-Hall, San Clements, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090211062 | Card and currency carrying device and method for using same - A card and currency carrying device is shown. The device includes a first side member assembly and a spaced second side member assembly. Each side member assembly has a flexible member, preferably stainless steel, having an undeflected position and a deflected position which is responsive to a compression deflection force applied concurrently to flexible members. A first pair and a second pair of support members are operatively connected to the flexible members. An elastic fabric material, preferably a woven elastic fabric material, having a thickness which reduces in dimension in response to a longitudinal tension force and which maintains its width dimension in response to a longitudinal tension force is operatively connected to the support members. | 08-27-2009 |
Rita Raisman-Vozari, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110319387 | INDOLE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES - The invention relates to a compound of the following formula (I), | 12-29-2011 |
Rita Rooyackers, Kassel-Lo BE
| Patent application number | Description | Published |
|---|---|---|
| 20090184358 | METHOD FOR FABRICATING A SEMICONDUCTOR DEVICE AND THE SEMICONDUCTOR DEVICE MADE THEREOF - A method for fabricating a semiconductor device and the device made thereof are disclosed. In one aspect, the method includes providing a substrate comprising a semiconductor material. The method further includes patterning at least one fin in the substrate, the fin comprising a top surface, at least one sidewall surface, and at least one corner. A supersaturation of point defects is created in the at least one fin. The at least one fin is annealed and then cooled down such that semiconductor atoms of the semiconductor material migrate via the point defects. | 07-23-2009 |
Rita Rooyackers, Kessel-Lo BE
| Patent application number | Description | Published |
|---|---|---|
| 20090137102 | METHOD FOR MAKING QUANTUM DOTS - A method for forming at least one quantum dot at least one predetermined location on a substrate is disclosed. In one aspect, the method comprises providing a layer of semiconductor material on an insulating layer on the substrate. The layer of semiconductor material is patterned so as to provide at least one line of semiconductor material having a width (w | 05-28-2009 |
| 20110253981 | METHOD OF MANUFACTURING A VERTICAL TFET - The present disclosure provides a method for manufacturing at least one nanowire Tunnel Field Effect Transistor (TFET) semiconductor device. The method comprises providing a stack comprising a layer of channel material with on top thereof a layer of sacrificial material, removing material from the stack so as to form at least one nanowire from the layer of channel material and the layer of sacrificial material, and replacing the sacrificial material in the at least one nanowire by heterojunction material. A method according to embodiments of the present disclosure is advantageous as it enables easy manufacturing of complementary TFETs. | 10-20-2011 |
Rita Rosentsveig, Rehovot IL
| Patent application number | Description | Published |
|---|---|---|
| 20100227782 | FULLERENE-LIKE NANOSTRUCTURES, THEIR USE AND PROCESS FOR THEIR PRODUCTION - A nanostructure, being either an Inorganic Fullerene-like (IF) nanostructure or an Inorganic Nanotube (INT), having the formula A | 09-09-2010 |
Rita Rovery, Forest Hills, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080284732 | Computer mouse bearing personalized and replaceable graphical indicia - A computer mouse is described comprising a bottom surface movable on a flat surface, an upper surface comprising a switch actuator portion, and a distending portion between the bottom surface and the upper surface. In the first embodiment of the present invention, a detachable and transparent hand rest portion is provided that can be affixed to the upper surface of the computer mouse. Graphical material can be placed beneath this detachable and transparent hand rest portion so that it is visible to the user. In a second embodiment of the present invention, a computer mouse comprises a bottom surface movable on a flat surface, an upper surface comprising a hand rest portion and a switch actuator portion, a distending portion between the bottom surface and the upper surface, and a detachable transparent cover overlaying said hand rest portion wherein said cover is sized to be selectively snapped on and off said computer mouse and incorporates sufficient space between the hand rest portion and said cover to permit placement of graphical material. In both preferred embodiments, the graphical material can be readily replaced at no additional costs. | 11-20-2008 |
Rita Sanvincenti, Firenze IT
| Patent application number | Description | Published |
|---|---|---|
| 20110205029 | SYSTEM FOR RECEIVING DATA FROM AN OBJECT - A system for receiving data from an object, whose particularity consists in comprising at least one radio frequency transponder adapted to be connected to an object, said transponder containing information related to the object that one wishes to send to a user, at least one receiving device, adapted to be carried by a user, being adapted to read said at least one transponder and to receive said information sent by said transponder and related to said object. | 08-25-2011 |
Rita Schmidt, Givataim IL
| Patent application number | Description | Published |
|---|---|---|
| 20100318002 | Acoustic-Feedback Power Control During Focused Ultrasound Delivery - Ultrasound energy is delivered to a patient in a controlled manner using a focused ultrasound system, thus maintaining the desired therapeutic effect without causing unwanted damage to surrounding tissue. An ultrasound transducer device includes multiple transducer elements, each of which is controlled by drive circuitry and a drive signal controller. An acoustic detector detects signals indicative of cavitation in tissue targeted by the transducer elements, and the drive signal controller manages the delivery of acoustic energy from the transducer elements based on the detected cavitation signals such that a therapeutic effect at the target tissue remains within an efficacy range. | 12-16-2010 |
| 20110034800 | ESTIMATION OF ALIGNMENT PARAMETERS IN MAGNETIC-RESONANCE-GUIDED ULTRASOUND FOCUSING - A magnetic-resonance-guided focused ultrasound system may be calibrated by generating ultrasound foci using ultrasound transducers, establishing coordinates of the foci and of magnetic-resonance trackers associated with the transducers, and determining a geometric relationship between the trackers and the transducers. | 02-10-2011 |
| 20110046472 | TECHNIQUES FOR TEMPERATURE MEASUREMENT AND CORRECTIONS IN LONG-TERM MAGNETIC RESONANCE THERMOMETRY - Techniques for temperature measurement and correction in long-term MR thermometry utilize a known temperature distribution in an MR imaging area as a baseline for absolute temperature measurement. Phase shifts that arise from magnetic field drifts are detected in one or more portions of the MR imaging area, facilitating correction of temperature measurements in an area of interest. | 02-24-2011 |
Rita Serda, Pearland, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20110311452 | INFLAMMATION TARGETING PARTICLES - Opsonizable micro- or nanoparticles, that contain at least one active agent, such as an imaging or therapeutic agent; that have a positive surface charge and that do not contain on their surface targeting ligands, such as antibodies, peptides or aptamers, can be used to treating and/or monitoring a condition associated with an inflammation, such as a cytokine stimulated inflammation. | 12-22-2011 |
Rita Sigueiro Ponte, Santiago De Compostela ES
| Patent application number | Description | Published |
|---|---|---|
| 20110213168 | DEUTERATED VITAMIN D COMPOUNDS - The invention relates to deuterated vitamin D compounds and the process for preparing and synthesizing a class of vitamin D compounds which can be isotopically substituted. These compounds can be used as internal standards in methods for the quantification of vitamin D, its metabolites and analogues by mass spectrometry. These compounds are described by means of general formula I. | 09-01-2011 |
Rita Slaaby, Lyngby DK
| Patent application number | Description | Published |
|---|---|---|
| 20100216715 | FGF21 Derivatives With Albumin Binder A-B-C-D-E- And Their Use - The present invention relates to Fibroblast Growth Factor 21 (FGF21), more in particular to derivatives of FGF21 compounds having an albumin binder of the formula A-B-C-D-E- covalently attached. The invention also relates to novel FGF21 analogues, as well as to the pharmaceutical use of these FGF21 derivatives and analogues, in particular for the treatment of diabetes, dyslipidemia, obesity, cardiovascular diseases, metabolic syndrome, and/or Non Alcoholic Fatty Liver Disease (NAFLD). The derivatives of the invention are protracted, e.g. capable of maintaining a low blood glucose level for a longer period of time, capable of increasing the in vivo half-life of FGF21, and/or result in a lower clearance of FGF21. The derivatives of the invention are preferably furthermore of an improved oxidative stability. | 08-26-2010 |
Rita Tewari, Nottingham GB
| Patent application number | Description | Published |
|---|---|---|
| 20110091526 | Parasite Vaccine - Compositions and methods for the development and use of a vaccine that includes one or more FusM antigens in a carrier adapted to trigger a FusM-specific immune response in the human blood stream are disclosed herein. | 04-21-2011 |
Rita Valenzuela Liminana, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20100041665 | N-PHENYL-PRENYLAMINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS - The present invention is related to a family of N-phenyl-prenylamine derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or Parkinson's Disease. The present invention also relates to pharmaceutical compositions comprising the same. Further, the present invention is directed to the use of the compounds in the manufacture of a medicament for the treatment and/or prevention of a cognitive, neurodegenerative or neuronal disease or disorder. | 02-18-2010 |
| 20100267827 | PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS - The present invention is related to a family of phenyl-prenyl-ether derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or 5 Parkinson's Disease. The present invention also relates to pharmaceutical compositions comprising the same. Further, the present invention is directed to the use of the compounds in the manufacture of a medicament for the treatment and/or prevention of a cognitive, neurodegenerative or neuronal disease or disorder. | 10-21-2010 |
Rita Vanbever, Brussels BE
| Patent application number | Description | Published |
|---|---|---|
| 20080253971 | Particles for inhalation having sustained release properties - The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylactic or diagnostic agent or any combination thereof in association with a charged lipid, wherein the charged lipid has an overall net charge which is opposite to that of the agent upon association with the agent. Release of the agent from the administered particles occurs in a sustained fashion. | 10-16-2008 |
Rita Vassena, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20090138979 | MANIPULATING SP1 ACTIVITY TO IMPROVE THERAPEUTIC CLONING - The observed over-expression of Sp1 target genes has inspired inventors to formulate a specific strategy for correcting many gene expression defects, and thus improve clone development. The invention is based on the belief that manipulating Sp1 activity can improve cloning. Inventors believe that cloning is inefficient in large part because of the continued expression of Sp1 target genes in the early cloned embryos, which causes clones to be very unlike normal embryos, and so makes them very unhealthy. Inventors propose that if over-expression of Sp1 target genes is prevented in early stage clones, this would greatly improve cloning efficiency by making the cloned embryos healthy again. | 05-28-2009 |
Rita Ventisette, Ponte A Egola (pl) IT
| Patent application number | Description | Published |
|---|---|---|
| 20100218743 | FASTENING ELEMENT AND FLUID INJECTOR ASSEMBLY - A Fastening element has a carrier. A first pair of prongs branches off a first side face of the carrier designed to be in a mechanical engagement with a protrusion of a injector cup. A second pair of prongs branches off a second side face of the carrier. The second pair of prongs is designed to retain a fluid injector and to couple mechanically to a first protrusion of the injector. A pair of pins branches off a respective prong from the second pair of prongs at a respective inner side face of the respective prong. The pins are arranged opposed to each other and in a given distance from each other and they are designed to be in a mechanical engagement with the fluid injector. A clamping device being designed to couple mechanically with the fluid injector cup and to exert a repelling force on the fluid injector cup. | 09-02-2010 |
Rita Zine, San Rafael, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100199917 | PET BED TUNNEL DEVICE - A pet bed having a base and a plush pad within the base which is sized to support a pet thereon. A tubular member is provided having one end affixed to the base and a non-rigid side wall, the non-rigid side wall being extendable from the base in a first orientation forming a tunnel from the plush pad and collapsible in a second orientation creating a side wall to the base. | 08-12-2010 |